Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
Kevin K. Gordon
Michael J. Gallagher, MD
Judith Teall
Tita Jeter
• With over 25 years of experience, Kevin K. Gordon has been appointed Chief Financial Officer of Quintiles (Triangle Park, NC).
• Michael J. Gallagher, MD, has been named Vice President and Global Head, Medical Affairs, at Kendle (Cincinnati, OH) where he will provide global leadership for the company's medical affairs organization. Jeffrey M. Zucker has been appointed as Senior Director and Global Head, Patient Recruitment.
• Exco InTouch (Hertfordshire, UK) has hired Judith Teall to fill its newly-created position of Director of Patient Recruitment.
• Copernicus Group IRB (Raleigh, NC) has made four additions to its team including Bill Van Nostrand as Vice President and Chief Business Development Officer, Tim Schuckman and Marcie Goodale as Regional Directors of Business Development, and Tita Jeter as Manager of Quality Assurance and Regulatory Compliance.
• PPD (Wilmington, NC) has appointed Henrietta Ukwu, MD, as Senior Vice President of Global Regulatory Affairs.
• As Health Decisions' (Durham, NC) Chief Technology Officer, Bryan Minihan will strengthen the company's proprietary HD360° technology platform.
• Previously the Senior Therapeutic Director for Oncology at i3, Jane Bentley, PhD, has joined Novella Clinical (Research Triangle Park, NC) as Vice President, Clinical Operations.
• CRF Health (Plymouth Meeting, PA) has hired Bonnie Teschendorf, PhD, as Patient Reported Outcomes Scientific Advisor where she will lead CRF Health's PRO consulting initiative providing scientific insight and guidance to clients and internal staff, as well as to the global clinical trial sector.
• Anthony Maida, PhD, will lead PharmaNet Development Group's (Princeton, NJ) oncology team in his new role as Vice President, Clinical Research.
• Carlos Martínez Manchado has joined Ricerca Bioscience's (Concord, OH) Analytical Chemistry department.
• Leading sales, marketing, and business development strategies for late stage business, Evelyn Graham will use her previous drug development experience as Worldwide Clinical Trials' (King of Prussia, PA) Executive Vice President, Global Business Development.
• Biomedical Systems (St. Louis, MO) has promoted Shanin Hagene to the position of Director of Contracts and Budgets where she will supervise a team of contract specialists in the St. Louis and Brussels offices, and Steven De Hertefelt has been hired to the position of Business Development Director, Europe.
• Synexus (Manchester, UK) has made several changes to its executive management team with the appointment of Christophe Berthoux, MD, as Chief Executive.
• Bringing with her more than 20 years experience, Julie Heneghan has been appointed Vice President of Advanced Clinical (Bannockburn,IL).
• Stuart Mudge, PhD, has been appointed Global Regulatory and Clinical Affairs Manager by HalcyGen Pharmaceuticals (Melbourne, Australia).
• CTI Clinical Trial and Consulting Services (Blue Ash, OH) promoted Nick Schatzman to Business Development Associate. Timothy Bockerstette has joined as Director, Business Development Operations.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.